Novel HIV1 Non-Nucleoside Reverse Transcriptase Inhibitor Agents: Optimization of Diarylanilines With High Potency Against Wild-Type and Rilpivirine-Resistant E138K Mutant Virus

doi 10.1021/acs.jmedchem.5b01827.s001
Full Text
Abstract

Available in full text

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2010English

Structure-Based Identification of HIV1 Nucleocapsid Protein Inhibitors Active Against Wild-Type and Drug-Resistant HIV1 Strains

English

Structure-Based Evaluation of Non-Nucleoside Inhibitors With Improved Potency and Solubility That Target HIV Reverse Transcriptase Variants

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2015English

Isolation and Characterization of Human Immunodeficiency Virus Type-1 Mutants Resistant to the Non-Nucleotide Reverse Transcriptase Inhibitor MKC-442

Antiviral Chemistry and Chemotherapy
MedicineVirologyDrug DiscoveryPharmacology
1995English

In Vitro Microbicidal Activity of the Nonnucleoside Reverse Transcriptase Inhibitor (NNRTI) UC781 Against NNRTI-Resistant Human Immunodeficiency Virus Type 1

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2006English

Multicenter Study of Skin Rashes and Hepatotoxicity in Antiretroviral-Naïve HIV-positive Patients Receiving Non-Nucleoside Reverse-Transcriptase Inhibitor Plus Nucleoside Reverse-Transcriptase Inhibitors in Taiwan

PLoS ONE
Multidisciplinary
2017English

Increased Polymerase Fidelity of E89G, a Nucleoside Analog-Resistant Variant of Human Immunodeficiency Virus Type 1 Reverse Transcriptase.

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
1996English

Non-Nucleoside Reverse Transcriptase Inhibitor Outcomes Among Combination Antiretroviral Therapy-Treated Adults in Botswana

AIDS
Infectious DiseasesAllergyImmunology
2010English

Pharmaceutical, Clinical, and Resistance Information on Doravirine, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor for the Treatment of HIV-1 Infection

Drugs in Context
Molecular MedicinePharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy